Home › Funds › Citigroup Inc › FDMT
Citigroup Inc position in FDMT
4D MOLECULAR THERAPEUTICS IN · Health Care
Latest position (Q2 2026)69.21K sh
Reported value held$920.52K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 2.80K | $76.00K | New |
| Q4 2021 | 83.17K | $1.82M | Add |
| Q1 2022 | 28.59K | $432.00K | Reduce |
| Q2 2022 | 12.24K | $85.00K | Reduce |
| Q3 2022 | 9.89K | $80.00K | Reduce |
| Q4 2022 | 25.82K | $573.37K | Add |
| Q1 2023 | 111.68K | $1.92M | Add |
| Q2 2023 | 58.16K | $1.05M | Reduce |
| Q3 2023 | 54.70K | $696.32K | Reduce |
| Q4 2023 | 41.31K | $836.90K | Reduce |
| Q1 2024 | 153.28K | $4.88M | Add |
| Q2 2024 | 82.81K | $1.74M | Reduce |
| Q3 2024 | 90.40K | $977.25K | Add |
| Q4 2024 | 93.62K | $521.47K | Add |
| Q1 2025 | 85.08K | $274.81K | Reduce |
| Q2 2025 | 22.80K | $84.57K | Reduce |
| Q3 2025 | 3.50K | $30.37K | Reduce |
| Q4 2025 | 12.66K | $94.94K | Add |
| Q1 2026 | 26.18K | $243.74K | Add |
| Q2 2026 | 69.21K | $920.52K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FDMT
- BlackRock Inc 4.55M sh · $60.46M · Q2 2026
- Goldman Sachs Group 4.26M sh · $56.64M · Q2 2026
- Janus Henderson Group 5.25M sh · $48.87M · Q1 2026
- Vanguard Group 3.09M sh · $23.20M · Q4 2025
- Geode Capital Management 1.13M sh · $15.01M · Q2 2026
- Bank of America Corp 1.12M sh · $14.90M · Q2 2026
- Deutsche Bank AG 710.94K sh · $9.46M · Q2 2026
- Renaissance Technologies 614.57K sh · $8.17M · Q2 2026
- Northern Trust Corp 562.93K sh · $7.49M · Q2 2026
- Morgan Stanley 503.02K sh · $6.69M · Q2 2026
- JPMorgan Chase & Co 402.14K sh · $5.18M · Q2 2026
- Charles Schwab Investment Management 339.27K sh · $4.51M · Q2 2026